Vertex Pharmaceuticals
VRTX
#179
Rank
โ‚น10.295 T
Marketcap
โ‚น40,155
Share price
1.75%
Change (1 day)
0.83%
Change (1 year)

Revenue for Vertex Pharmaceuticals (VRTX)

Revenue in 2025 (TTM): โ‚น1.014 Trillion

According to Vertex Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น1.058 Trillion. In 2024 the company made a revenue of โ‚น945.37 Billion an increase over the revenue in the year 2023 that were of โ‚น821.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vertex Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น1.014 T7.26%
2024 โ‚น945.37 B15.07%
2023 โ‚น821.59 B11.17%
2022 โ‚น739.01 B31.08%
2021 โ‚น563.76 B24.22%
2020 โ‚น453.84 B52.88%
2019 โ‚น296.85 B39.31%
2018 โ‚น213.09 B34.1%
2017 โ‚น158.90 B37.37%
2016 โ‚น115.67 B68.61%
2015 โ‚น68.60 B86.5%
2014 โ‚น36.78 B-50.87%
2013 โ‚น74.87 B-10.45%
2012 โ‚น83.61 B12.04%
2011 โ‚น74.62 B1061.54%
2010 โ‚น6.42 B35.89%
2009 โ‚น4.72 B-43.96%
2008 โ‚น8.43 B8.01%
2007 โ‚น7.81 B-18.49%
2006 โ‚น9.58 B32.35%
2005 โ‚น7.24 B62.75%
2004 โ‚น4.44 B46.68%
2003 โ‚น3.03 B-60.74%
2002 โ‚น7.72 B20.92%
2001 โ‚น6.38 B73.84%
2000 โ‚น3.67 B58.54%
1999 โ‚น2.31 B34.59%
1998 โ‚น1.72 B0.04%
1997 โ‚น1.72 B260.01%
1996 โ‚น0.47 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
โ‚น2.626 T 148.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น5.386 T 408.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.801 T 447.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.337 T 309.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.321 T 686.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
โ‚น5.85 B-99.45%๐Ÿ‡บ๐Ÿ‡ธ USA